92188-49-3 Usage
General Description
1-(3-Methoxy-phenyl)-2-methylamino-ethanol is a chemical compound that consists of a 3-methoxyphenyl group attached to a 2-methylaminoethanol moiety. It is also known as 3-methoxyphenyl-2-methylaminoethanol. 1-(3-METHOXY-PHENYL)-2-METHYLAMINO-ETHANOL is used in the pharmaceutical industry as a potential drug candidate due to its structural features and potential pharmacological properties. It may have applications in the development of medications for various medical conditions. The chemical structure and properties of 1-(3-Methoxy-phenyl)-2-methylamino-ethanol make it a subject of interest for research and development in the pharmaceutical field.
Check Digit Verification of cas no
The CAS Registry Mumber 92188-49-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,1,8 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 92188-49:
(7*9)+(6*2)+(5*1)+(4*8)+(3*8)+(2*4)+(1*9)=153
153 % 10 = 3
So 92188-49-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO2/c1-11-7-10(12)8-4-3-5-9(6-8)13-2/h3-6,10-12H,7H2,1-2H3
92188-49-3Relevant articles and documents
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases
Schnute, Mark E.,Anderson, David J.,Brideau, Roger J.,Ciske, Fred L.,Collier, Sarah A.,Cudahy, Michele M.,Eggen, MariJean,Genin, Michael J.,Hopkins, Todd A.,Judge, Thomas M.,Kim, Euibong J.,Knechtel, Mary L.,Nair, Sajiv K.,Nieman, James A.,Oien, Nancee L.,Scott, Allen,Tanis, Steven P.,Vaillancourt, Valerie A.,Wathen, Michael W.,Wieber, Janet L.
, p. 3349 - 3353 (2008/02/07)
A novel series of 2-aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potent antivirals against human herpesviruses. These compounds demonstrate broad-spectrum inhibition of the herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases.
Pyridoquinoxaline antivirals
-
, (2008/06/13)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
